ProUroCare (PUMD:NASDAQ), based in Minneapolis, Minnesota, announced that Dr. Michael Chambers has been named to its Board of Directors.

ProUroCare (PUMD:NASDAQ), based in Minneapolis, Minnesota, announced that Dr. Michael Chambers has been named to its Board of Directors.  Dr. Chambers is the President and CEO of Swift Biotech. Our The ProUroScanTM prostate imaging systemwas designed to produce an elasticity image of the prostate as an adjunctive aid in visualizing and documenting abnormalities in the prostate that have been detected by digital rectal examination.  The system’s breakthrough technology provides cost-effective, high-quality images in real-time.